Tell the FDA that PRP Treatments Should Be Exempt from Regulation!

Platelet-rich-plasma (PRP) injections are used by orthopedic doctors to treat bone and joint pain. Blood is drawn from a patient, platelets are separated from other components of the blood using a centrifuge, then the platelet-rich blood is injected into arthritic joints. PRP is safer, less costly, has a more rapid recovery time, and shows promising results.

According to FDA rules, if you remove blood cells from an individual and implant them back into the same individual during the same surgical procedure, you are exempted from the FDA’s regulations—but spinning blood in a centrifuge for PRP treatment is not mentioned explicitly. It’s unclear whether this is a conscious move by the FDA to make it more difficult and costly to perform PRP treatments, or an error of omission.

Please urge the FDA to clearly indicate that PRP treatments using in-office centrifuges are exempt from their regulations.

Please personalize and add your own comments if you have time!


  • Division of Dockets Management of the FDA


*Required fields


PRP Treatments Should Be Exempt from FDA Regulation!

Dear [Decision Maker],

[Your Name]
[Your Address]
[City, State ZIP]